MiMedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MDXG•Federal court ruling on Axiofill classification
Sept. 24 (Reuters) - MiMedx Group, Inc. MDXG.O:
- MiMedx announces favorable federal court ruling in Axiofill® regulatory classification matter.
- MiMedx Group: Court vacates FDA determinations that Axiofill is not minimally manipulated and should be classified as a biological product.
- MiMedx Group: Court concludes FDA classification of Axiofill as a biological product was "arbitrary and capricious".
